Data as of Mar 07
| -0.01 / -0.02%|
The 1 analysts offering 12-month price forecasts for Utah Medical Products Inc have a median target of 50.30, with a high estimate of 50.30 and a low estimate of 50.30. The median estimate represents a -9.37% decrease from the last price of 55.50.
The current consensus among 2 polled investment analysts is to Buy stock in Utah Medical Products Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.